Miltenyi Biotec GmbH-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Miltenyi Biotec GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014022
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company’s services include sample preparation, cell separation, flow cytometry, cell culture and stimulation, molecular, clinical applications and viscover imaging. It also offers cytometers, analyzers, reagents, buffers, imaging instruments, and software solutions. Miltenyi conducts research in the areas of oncology, cardiovascular disease, metabolic disorders, immunology, neurology and infection. The company has presence in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea, and others. Miltenyi is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.

Miltenyi Biotec GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Venture Financing 12
Owl Biomedical Raises US$3 Million In Series A Financing 12
Partnerships 13
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Miltenyi Biotec Enters Into Co-Development Agreement With TeutoCell For Novel Cell Culture Media 16
Licensing Agreements 17
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Miltenyi Biotec Enters into Licensing Agreement with Genethon 18
Accellta Enters into Licensing Agreement with Miltenyi Biotec 19
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 20
Asset Transactions 21
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 21
Acquisition 22
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH – Key Competitors 25
Miltenyi Biotec GmbH – Key Employees 26
Miltenyi Biotec GmbH – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Legal and Regulatory 29
Sep 19, 2016: CE marked MACS IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Devices Deals, 2011 to YTD 2017 9
Miltenyi Biotec GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 11
Owl Biomedical Raises US$3 Million In Series A Financing 12
GlaxoSmithKline Enters into Agreement with Miltenyi Biotec 13
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 14
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 15
Miltenyi Biotec Enters Into Co-Development Agreement With TeutoCell For Novel Cell Culture Media 16
Living Pharma Enters into Licensing Agreement with University of Maryland, Baltimore 17
Miltenyi Biotec Enters into Licensing Agreement with Genethon 18
Accellta Enters into Licensing Agreement with Miltenyi Biotec 19
Nanolek To Enter Into Licensing Agreement With Lentigen For Flu Vaccine 20
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen 21
Lentigen Technology Acquires Living Pharma 22
Miltenyi Biotec Acquires Sensovation 23
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 24
Miltenyi Biotec GmbH, Key Competitors 25
Miltenyi Biotec GmbH, Key Employees 26
Miltenyi Biotec GmbH, Other Locations 27
Miltenyi Biotec GmbH, Subsidiaries 27

★海外企業調査レポート[Miltenyi Biotec GmbH-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NuVasive Inc (NUVA):製品パイプライン分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Superior Industries International, Inc.:企業の戦略・SWOT・財務情報
    Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Industries International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Curie Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Curie Institute is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biolo …
  • Companhia Energetica de Sao Paulo (CESP6)-エネルギー分野:企業M&A・提携分析
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company generates energy from hydro source. CESP owns power plants at at Rio Paran, Rio Paraibuna, and Rio J …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lundin Mining Corporation:企業のM&A・事業提携・投資動向
    Lundin Mining Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lundin Mining Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Beijing Enterprises Holdings Ltd:企業の戦略・SWOT・財務情報
    Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Beijing Enterprises Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Intersnack Group GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Schweitzer Engineering Laboratories Inc:企業の戦略的SWOT分析
    Schweitzer Engineering Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Evine Live Inc.:企業の戦略・SWOT・財務分析
    Evine Live Inc. - Strategy, SWOT and Corporate Finance Report Summary Evine Live Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Phatra Leasing Public Company Limited (PL):企業の財務・戦略的SWOT分析
    Phatra Leasing Public Company Limited (PL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Waterloo Industries Inc:企業の戦略的SWOT分析
    Waterloo Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Surgical Care Affiliates LLC (SCAI):企業の財務・戦略的SWOT分析
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • GfK SE:企業の戦略・SWOT・財務情報
    GfK SE - Strategy, SWOT and Corporate Finance Report Summary GfK SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Ampio Pharmaceuticals Inc (AMPE):製薬・医療:M&Aディール及び事業提携情報
    Summary Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by …
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Coda Octopus Group Inc:企業の戦略・SWOT・財務情報
    Coda Octopus Group Inc - Strategy, SWOT and Corporate Finance Report Summary Coda Octopus Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Royal IHC:石油・ガス:M&Aディール及び事業提携情報
    Summary Royal IHC (IHC), formerly IHC Merwede BV is a shipbuilding company that offers engineering solutions. The company’s product portfolio includes dredging equipment, motion control and automation equipment, decommissioning equipment, offshore foundation equipment and metal construction kits. IH …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆